Long-term results of clam enterocystoplasty in non-neurogenic refractory urge incontinence

Abstract

Objectives: This study aims to assess the efficacy of Clam enterocystoplasty (CECP) surgery for the treatment of non-neurogenic refractory urgency urinary incontinence (UUI). Methods: We conducted a retrospective evaluation of 17 female patients who underwent CECP for non-neurogenic refractory UUI between May 2010 and November 2022. Results: The median of ICIQ-SF was 19 (15–21) before treatment, which decreased to a median of 0 (0–5) after treatment ( p = 0.01). The average preoperative pad use among the participants was 4 (3–6), while it became 0 postoperatively ( p < 0.01). The median preoperative cystometric bladder capacity was 251 ml (100–350 ml), increasing to 456 ml (400–650 ml) postoperatively ( p < 0.01). According to the Clavien-Dindo classification system, the majority of patients experienced either no complications (66%) or minor complications (CD I/CD II) (33%) within the initial 90 days following surgery. Conclusions: “Clam” iliocystoplasty emerges as a secure and successful treatment option in the patient group whose symptoms persist after first, second, and third-line treatments with the diagnosis of urge incontinence.